The Oncology Institute TOI Stock
The Oncology Institute Price Chart
The Oncology Institute TOI Financial and Trading Overview
| The Oncology Institute stock price | 1.28 USD |
| Previous Close | 0.49 USD |
| Open | 0.56 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 900 |
| Day's Range | 0.52 - 0.61 USD |
| 52 Week Range | 0.33 - 7.6 USD |
| Volume | 2.73M USD |
| Avg. Volume | 765.9K USD |
| Market Cap | 45.65M USD |
| Beta (5Y Monthly) | 0.878094 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.92 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.5 USD |
TOI Valuation Measures
| Enterprise Value | 91.58M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.0267797 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.16689388 |
| Price/Book (mrq) | 0.45412293 |
| Enterprise Value/Revenue | 0.335 |
| Enterprise Value/EBITDA | -1.446 |
Trading Information
The Oncology Institute Stock Price History
| Beta (5Y Monthly) | 0.878094 |
| 52-Week Change | -90.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.6 USD |
| 52 Week Low | 0.33 USD |
| 50-Day Moving Average | 0.51 USD |
| 200-Day Moving Average | 2.01 USD |
TOI Share Statistics
| Avg. Volume (3 month) | 765.9K USD |
| Avg. Daily Volume (10-Days) | 3.64M USD |
| Shares Outstanding | 75.35M |
| Float | 32.15M |
| Short Ratio | 6.35 |
| % Held by Insiders | 19.96% |
| % Held by Institutions | 71.89% |
| Shares Short | 1.36M |
| Short % of Float | 4.90% |
| Short % of Shares Outstanding | 1.80% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -17.96% |
| Operating Margin (ttm) | -24.87% |
| Gross Margin | 19.69% |
| EBITDA Margin | -23.15% |
Management Effectiveness
| Return on Assets (ttm) | -19.27% |
| Return on Equity (ttm) | -42.64% |
Income Statement
| Revenue (ttm) | 273.51M USD |
| Revenue Per Share (ttm) | 3.76 USD |
| Quarterly Revenue Growth (yoy) | 38.10% |
| Gross Profit (ttm) | 52.09M USD |
| EBITDA | -63330000 USD |
| Net Income Avi to Common (ttm) | -40193000 USD |
| Diluted EPS (ttm) | -0.65 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 55.38M USD |
| Total Cash Per Share (mrq) | 0.74 USD |
| Total Debt (mrq) | 110.03M USD |
| Total Debt/Equity (mrq) | 111.82 USD |
| Current Ratio (mrq) | 3.954 |
| Book Value Per Share (mrq) | 1.334 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60227000 USD |
| Levered Free Cash Flow (ttm) | -41483624 USD |
Profile of The Oncology Institute
| Country | United States |
| State | CA |
| City | Cerritos |
| Address | 18000 Studebaker Road |
| ZIP | 90703 |
| Phone | 562 735 3226 |
| Website | https://theoncologyinstitute.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 750 |
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Q&A For The Oncology Institute Stock
What is a current TOI stock price?
The Oncology Institute TOI stock price today per share is 1.28 USD.
How to purchase The Oncology Institute stock?
You can buy TOI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for The Oncology Institute?
The stock symbol or ticker of The Oncology Institute is TOI.
Which industry does the The Oncology Institute company belong to?
The The Oncology Institute industry is Medical Care Facilities.
How many shares does The Oncology Institute have in circulation?
The max supply of The Oncology Institute shares is 74.31M.
What is The Oncology Institute Price to Earnings Ratio (PE Ratio)?
The Oncology Institute PE Ratio is now.
What was The Oncology Institute earnings per share over the trailing 12 months (TTM)?
The Oncology Institute EPS is -0.92 USD over the trailing 12 months.
Which sector does the The Oncology Institute company belong to?
The The Oncology Institute sector is Healthcare.
The Oncology Institute TOI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}